ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1433

The Role of Patient and Parental Resilience in Amplified Musculoskeletal Pain Syndrome

Sabrina Gmuca1, Audrey Urquhart1, Pamela F. Weiss2, Jeffrey S. Gerber3 and David D. Sherry1, 1Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Division of Rheumatology, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Chronic pain, pediatric rheumatology and resiliency

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Resilience is a dynamic process of positive adaptation in the context of significant adversity. While higher levels of resilience have been associated with improved physical function and reduced depression and pain in adults with chronic musculoskeletal pain, our knowledge regarding the role of resilience in children with amplified musculoskeletal pain syndrome (AMPS) is limited. We aimed to 1) measure the level of resilience among patients with amplified musculoskeletal pain syndrome and one of their caregivers and 2) determine factors associated with patient resilience.

Methods: This was a prospective inception cohort study of children ages 13-17 years diagnosed with AMPS and one of their caregivers. Eligible subjects were seen for an initial consultation in the pediatric rheumatology pain clinic from March 2018 – May 2018. Subject-caregiver pairs completed online questionnaires including demographic surveys and two measures of resilience: The 14-Item Resilience Scale (RS-14) and the Connor-Davidson Resilience Scale 10-item (CD-RISC-10). Children completed another resilience measure, the 7 Cs Tool. Clinical and demographic variables were abstracted from electronic medical records. We performed multivariate linear regression analyses, using stepwise forward selection with p<0.2, to explore the relationship between patient resilience (using CD-RISC-10) and variables of interest including parental resilience.

Results: 20 patient-proxy pairs were included. The majority of patients were female (75%) and Caucasian (70%). Parents were predominantly mothers (95%) and Caucasian (95%). Table 1 shows other demographic variables. 95% of children had ≥ 1 adverse childhood experience (ACEs) with parental separation being the most common (20%). According to the RS-14, both children and parents had moderate resilience (Table). On the CD-RISC-10, children had a mean score of 26.5 (SD 7.0) and parents had a mean score 28.9 (SD 6.5). This compares to a mean level of resilience of 30.1 (SD 5.3) among a normative student sample (Hartley MT, 2012). According to the 7 C’s Tool, the mean level of patient resilience was low (total score ≥ 3), with a mean of 3.05 (SD 1.7). All measures of resilience were statistically significantly correlated with one another (p<0.05). From the final regression model, higher patient resilience was found to be associated with lower pain scores (β=-0.17), less depression (β=-4.9), more ACEs (β=1.93), older age (β=1.92), and a lower symptom severity score (β=-0.63) (all p<0.02). Parental resilience did not contribute significantly to the model (p>0.2).

Conclusion: Children with AMPS and their parents had low to moderate levels of resilience. Higher patient resilience was associated with lower disease burden among children with AMPS. Resilience-training interventions serve as potential treatment modalities for this patient population.

 


Disclosure: S. Gmuca, None; A. Urquhart, None; P. F. Weiss, Lilly, 5, 9; J. S. Gerber, None; D. D. Sherry, None.

To cite this abstract in AMA style:

Gmuca S, Urquhart A, Weiss PF, Gerber JS, Sherry DD. The Role of Patient and Parental Resilience in Amplified Musculoskeletal Pain Syndrome [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-role-of-patient-and-parental-resilience-in-amplified-musculoskeletal-pain-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-patient-and-parental-resilience-in-amplified-musculoskeletal-pain-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology